Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil might help treat acne scars by reducing collagen buildup.

Cyclophosphamide helped 59.4% of children with steroid-resistant nephrotic syndrome but caused side effects in 40.6%.

Water and fatty acids affect hair's surface differently based on hair damage, and models can help understand hair-cosmetic interactions.

STK11 gene variations do not predict how well metformin will work for PCOS, but may affect hair loss and excess hair growth.

Acupressure improves quality of life in PCOS patients.

Human hair keratins can be turned into useful 3D biomedical scaffolds through a freeze-thaw process.

Taking Kera-Diet® improves hair and nail health without side effects.

Women with PCOS have higher levels of certain androgens, which are good at predicting excess hair growth.

Using lidocaine before keloid injections makes the treatment more comfortable for patients.

Proper care and diet are crucial to prevent health issues in gerbils.

Women with PCOS had higher SRAGE levels, possibly linked to BMI, not PCOS.

Spironolactone can cause side effects like high potassium levels and breast enlargement, and patients need careful monitoring.

Second-generation antipsychotics offer no significant benefit over first-generation ones for schizophrenia.

Microneedling combined with platelet-rich plasma therapy is more effective for hair regrowth in androgenic alopecia than microneedling alone, but it's more painful.

Topical finasteride with EGCG or TA improves drug release and dermal uptake, potentially treating hair loss effectively.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Improving artificial vascular grafts requires better materials and surface designs to reduce blood clotting and support blood vessel cell growth.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Auxin and ethylene hormones both work together and against each other to control plant growth.

Certain proteins, Lgr5 and Lgr6, are important markers of adult stem cells and are involved in tissue repair and cancer development.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Sorafenib is effective in treating Desmoid Tumor/Deep Fibromatosis.